← 產業報告目錄

Hemostasis and Tissue Sealing Agents Market Research Report Information by Product (Topical Hemostat, Adhesive & Tissue Sealant), By Material (Chitosan-based Products, Mineral based Products), By Application (Trauma, General Surgery, Minimally Invasive Surgery, Gynecology Others), By End-User (Hospitals, Ambulatory Surgical Centers, Research Institutes), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-08-10頁數 132報告編號 MRFRHC6090CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Hemostasis and Tissue Sealing Agents Market Research Report Information by Product (Topical Hemostat, Adhesive & Tissue Sealant), By Material (Chitosan-based Products, Mineral based Products), By Application (Trauma, General Surgery, Minimally Invasive Surgery, Gynecology Others), By End-User (Hospitals, Ambulatory Surgical Centers, Research Institutes), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032 Market Overview In 2023, the market size of hemostasis and tissue sealing agents was estimated to be USD 8.39 billion. During the forecast period (2024-2032), the Hemostasis and Tissue Sealing Agents Market industry is anticipated to experience a compound annual growth rate (CAGR) of 8.04%, increasing from USD 9.02 billion in 2024 to USD 18.19 billion by 2032. The market is being driven by the increasing prevalence of chronic blood disorders and road accidents, the global preference for minimally invasive procedures, and the aging population. Another factor that is driving the market's growth is the increasing prevalence of chronic blood disorders. Due to impaired clotting factors, individuals with specific blood disorders, including hemophilia or von Willebrand disease, are at an elevated risk of hemorrhaging. It may be necessary for individuals with these disorders to use hemostasis agents during surgical procedures or medical interventions, as they facilitate blood clotting and control hemorrhage. For example, the 2022 update from the International Society on Thrombosis and Hemostasis indicates that approximately 10 million cases of venous thromboembolism occur annually on a global scale. Deep vein thrombosis (DVT) is responsible for the deaths of 544,000 individuals in Europe each year, as per the same source. Market segment insights The market is segmented into Topical hemostats and adhesive and tissue sealants comprise market segmentation by product. The market segmentation is predicated on a material that encompasses mineral-based products and chitosan-based products. Hospitals, ambulatory surgical centers, and research institutes comprise the market segmentation, which is predicated on end-users. Regional Perspectives The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. In 2023, the North American Hemostasis and Tissue Sealing Agents market held the largest market share. This is a result of the ongoing advancements in medical technology, the growing prevalence of chronic diseases, and the geriatric population. The market has become a center for research and development, resulting in the introduction of innovative products with superior efficacy, with a concentration on improving patient outcomes and reducing postoperative complications. The European Hemostasis and Tissue Sealing Agents market is anticipated to have the second-largest market share, because of the trend toward the integration of Hemostasis and tissue sealing agents, including counseling, and favorable health policies. In addition, the German Hemostasis and Tissue Sealing Agents market was identified as having the largest market share, while the French Hemostasis and Tissue Sealing Agents market is anticipated to experience the quickest growth in the European region. It is anticipated that the Asia-Pacific Hemostasis and Tissue Sealing Agents market will experience the most rapid growth from 2024 to 2032. This is the result of a growing middle class, accelerated economic growth, and increased urbanization. The demand for healthcare, technology, and consumer products is driven by the region's growing population. Industrial growth and innovation are stimulated by robust investments in infrastructure, education, and technology. The Middle East, Africa, and Latin America comprise the Rest of the World. The primary factors that influence the growth of Hemostasis and Tissue Sealing Agents in the Middle East and Africa. The Middle East and Africa region has encountered The demand for sophisticated medical products is being driven by the expansion of healthcare infrastructure and the increase in healthcare expenditure. The primary market players Johnson & Johnson (US), B Braun Medical Inc (Germany), Teleflex Incorporated (US), Medtronic (Ireland), Baxter (US), Medtrade Products Limited (UK), Axio Biosolutions Pvt Ltd (India), MIL Laboratories Pvt. Ltd (India), Becton, Dickinson, and Company (US), and Pfizer Inc (US) are the primary players in the market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 3.2 DATA FLOW 3.2.1 Data Mining Process 3.3 PURCHASED DATABASE: 3.4 SECONDARY SOURCES: 3.4.1 Secondary Research data flow: 3.5 PRIMARY RESEARCH: 3.5.1 Primary Research Data Flow: 3.5.2 Primary Research: Number of Interviews conducted 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 3.6.1 Revenue Analysis Approach 3.7 DATA FORECASTING 3.7.1 Data forecasting Technique 3.8 DATA MODELLING 3.8.1 Microeconomic Factor Analysis: 3.8.2 Data Modelling: 3.9 TEAMS AND ANALYST CONTRIBUTION 4 MARKET DYNAMICS 4.1 INTRODUCTION 4.1 DRIVERS 4.1.1 Growing Incidences Of Road Accidents And Chronic Blood Disorders 4.1.2 Growing Preference Of Minimally Invasive Procedures 4.2 RESTRAINTS 4.2.1 High Costs and Stringent Regulatory Requirements 4.3 OPPORTUNITY 4.3.1 Growing Incidences Of Road Accidents And Growing Geriatric Population 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 Research & Development 5.1.2 Manufacturing 5.1.3 Distribution 5.1.4 Marketing & Sales 5.1.5 Post-Sales Monitoring 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 bargaining power of buyers 5.2.2 Bargaining Power of Suppliers 5.2.3 Threat of New Entrants 5.2.4 THREAT OF SUBSTITUTES 5.2.5 Intensity of Rivalry 5.3 IMPACT OF COVID-19 5.4 HEMOSTASIS AND TISSUE SEALING AGENTS FOR MILITARY PURPOSE 6 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT 6.1 OVERVIEW 6.2 TOPICAL HEMOSTAT 6.2.1 Active 6.2.2 Mechanical 6.2.3 Flowable 6.3 ADHESIVE & TISSUE SEALANT 6.3.1 Synthetic Tissue Sealant 6.3.2 Natural Tissue Sealant 6.3.3 Adhesion Barrier Products 7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL 7.1 OVERVIEW 7.2 CHITOSAN-BASED PRODUCTS 7.3 MINERAL BASED PRODUCTS 8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION 8.1 OVERVIEW 8.2 TRAUMA 8.2.1 Burns 8.2.2 Accidents 8.2.2.1 Major Accidents 8.2.2.2 Minor Accidents 8.2.3 Others 8.3 GENERAL SURGERY 8.4 MINIMALLY INVASIVE SURGERY 8.5 GYNAECOLOGY 8.6 OTHERS 9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER 9.1 OVERVIEW 9.2 HOSPITALS 9.2.1 Public 9.2.2 Private 9.2.3 Military 9.3 AMBULATORY SURGICAL CENTERS 9.3.1 Independent Ambulatory Surgical Centers 9.3.2 Military Ambulatory Surgical Centers 9.4 RESEARCH INSTITUTES 10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION 10.1 OVERVIEW 10.2 NORTH AMERICA 10.2.1 US 10.2.2 CANADA 10.3 EUROPE 10.3.1 Germany 10.3.2 France 10.3.3 UK 10.3.4 Italy 10.3.5 spain 10.3.6 Rest of Europe 10.4 ASIA-PACIFIC 10.4.1 China 10.4.2 India 10.4.3 Japan 10.4.4 Australia 10.4.5 South Korea 10.4.6 Rest of Asia-Pacific 10.5 REST OF THE WORLD 10.5.1 Middle East & Africa 10.5.2 South America 11 COMPETITIVE LANDSCAPE 11.1 INTRODUCTION 11.2 MARKET SHARE ANALYSIS, 2022 11.3 COMPETITOR DASHBOARD 11.4 PUBLIC PLAYERS STOCK SUMMARY 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.6.1 product launch / Product approval 11.6.2 Acquisition 12 COMPANY PROFILES 12.1 JOHNSON & JOHNSON SERVICES, INC 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 productS OFFERED 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT ANALYSIS 12.1.6 KEY STRATEGIES 12.2 B. BRAUN SE 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 products OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 KEY STRATEGIES 12.3 MIL LABORATORIES PVT. LTD 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 productS OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 KEY STRATEGIES 12.4 BECTON, DICKINSON, AND COMPANY 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS OFFERED 12.4.4 KEY DEVELOPMENTS 12.4.5 KEY STRATEGIES 12.5 PFIZER INC. 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 SWOT ANALYSIS 12.5.6 KEY STRATEGIES 12.6 TELEFLEX INCORPORATED 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 TELEFLEX INCORPORATED: kEY DEVELOPMENTS 12.6.6 KEY STRATEGIES 12.7 MEDTRONIC 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS OFFERED 12.7.4 KEY DEVELOPMENTS 12.7.5 SWOT ANALYSIS 12.7.6 KEY STRATEGIES 12.8 BAXTER 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 SWOT ANALYSIS 12.8.6 KEY STRATEGIES 12.9 MEDTRADE PRODUCTS LIMITED 12.9.1 COMPANY OVERVIEW 12.9.2 FINANCIAL OVERVIEW 12.9.3 PRODUCTS OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 SWOT ANALYSIS 12.9.6 KEY STRATEGIES 12.10 AXIO BIOSOLUTIONS PVT LTD 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 KEY STRATEGIES 13 DATA CITATIONS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT 38 TABLE 2 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 54 TABLE 3 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY REGION, 2019–2032 (USD MILLION) 55 TABLE 4 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 55 TABLE 5 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACTIVE, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 6 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MECHANICAL, BY REGION, 2019–2032 (USD MILLION) 56 TABLE 7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR FLOWABLE, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY REGION, 2019–2032 (USD MILLION) 57 TABLE 9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 57 TABLE 10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR SYNTHETIC TISSUE SEALANT, BY REGION, 2019–2032 (USD MILLION) 58 TABLE 11 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR NATURAL TISSUE SEALANT, BY REGION, 2019–2032 (USD MILLION) 58 TABLE 12 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESION BARRIER PRODUCTS, BY REGION, 2019–2032 (USD MILLION) 59 TABLE 13 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 62 TABLE 14 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR CHITOSAN-BASED PRODUCTS, BY REGION, 2019–2032 (USD MILLION) 62 TABLE 15 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINERAL BASED PRODUCTS, BY REGION, 2019–2032 (USD MILLION) 63 TABLE 16 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 65 TABLE 17 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY REGION, 2019–2032 (USD MILLION) 66 TABLE 18 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 66 TABLE 19 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR BURNS, BY REGION, 2019–2032 (USD MILLION) 67 TABLE 20 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY REGION, 2019–2032 (USD MILLION) 67 TABLE 21 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 67 TABLE 22 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MAJOR ACCIDENTS, BY REGION, 2019–2032 (USD MILLION) 69 TABLE 23 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINOR ACCIDENTS, BY REGION, 2019–2032 (USD MILLION) 69 TABLE 24 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 70 TABLE 25 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR GENERAL SURGERY, BY REGION, 2019–2032 (USD MILLION) 70 TABLE 26 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MINIMALLY INVASIVE SURGERY, BY REGION, 2019–2032 (USD MILLION) 71 TABLE 27 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR GYNAECOLOGY, BY REGION, 2019–2032 (USD MILLION) 71 TABLE 28 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) 72 TABLE 29 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 74 TABLE 30 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION) 75 TABLE 31 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 75 TABLE 32 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR PUBLIC, BY REGION, 2019–2032 (USD MILLION) 76 TABLE 33 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR PRIVATE, BY REGION, 2019–2032 (USD MILLION) 76 TABLE 34 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MILITARY, BY REGION, 2019–2032 (USD MILLION) 77 TABLE 35 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION) 77 TABLE 36 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 78 TABLE 37 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR INDEPENDENT AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION) 78 TABLE 38 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR MILITARY AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION) 78 TABLE 39 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2019–2032 (USD MILLION) 79 TABLE 40 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2019–2032 (USD MILLION) 81 TABLE 41 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 83 TABLE 42 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 83 TABLE 43 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 84 TABLE 44 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 84 TABLE 45 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 84 TABLE 46 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 85 TABLE 47 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 85 TABLE 48 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 85 TABLE 49 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 86 TABLE 50 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 86 TABLE 51 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 86 TABLE 52 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 87 TABLE 53 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 87 TABLE 54 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 87 TABLE 55 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 88 TABLE 56 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 88 TABLE 57 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 88 TABLE 58 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 89 TABLE 59 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 89 TABLE 60 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 89 TABLE 61 US: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 90 TABLE 62 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 90 TABLE 63 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 90 TABLE 64 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 91 TABLE 65 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 91 TABLE 66 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 91 TABLE 67 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 92 TABLE 68 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 92 TABLE 69 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 92 TABLE 70 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 93 TABLE 71 CANADA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 93 TABLE 72 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 95 TABLE 73 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 95 TABLE 74 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 96 TABLE 75 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 96 TABLE 76 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 96 TABLE 77 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 98 TABLE 78 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 98 TABLE 79 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 98 TABLE 80 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 99 TABLE 81 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 99 TABLE 82 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 99 TABLE 83 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 100 TABLE 84 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 100 TABLE 85 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 100 TABLE 86 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 101 TABLE 87 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 101 TABLE 88 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 101 TABLE 89 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 102 TABLE 90 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 102 TABLE 91 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 102 TABLE 92 GERMANY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 103 TABLE 93 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 103 TABLE 94 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 103 TABLE 95 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 104 TABLE 96 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 104 TABLE 97 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 104 TABLE 98 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 105 TABLE 99 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 105 TABLE 100 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 105 TABLE 101 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 106 TABLE 102 FRANCE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 106 TABLE 103 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 106 TABLE 104 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 107 TABLE 105 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 107 TABLE 106 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 107 TABLE 107 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 108 TABLE 108 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 108 TABLE 109 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 108 TABLE 110 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 109 TABLE 111 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 109 TABLE 112 UK: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 109 TABLE 113 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 110 TABLE 114 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 110 TABLE 115 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 110 TABLE 116 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 111 TABLE 117 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 111 TABLE 118 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 111 TABLE 119 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 112 TABLE 120 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 112 TABLE 121 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 112 TABLE 122 ITALY: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 113 TABLE 123 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 113 TABLE 124 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 113 TABLE 125 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 114 TABLE 126 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 114 TABLE 127 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 114 TABLE 128 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 115 TABLE 129 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 115 TABLE 130 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 115 TABLE 131 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 116 TABLE 132 SPAIN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 116 TABLE 133 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 116 TABLE 134 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TOPICAL HEMOSTAT, BY TYPE 2019–2032 (USD MILLION) 117 TABLE 135 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ADHESIVE & TISSUE SEALANT, BY TYPE 2019–2032 (USD MILLION) 117 TABLE 136 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 117 TABLE 137 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 118 TABLE 138 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR TRAUMA, BY TYPE 2019–2032 (USD MILLION) 118 TABLE 139 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR ACCIDENTS, BY TYPE 2019–2032 (USD MILLION) 118 TABLE 140 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 119 TABLE 141 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR HOSPITALS, BY TYPE 2019–2032 (USD MILLION) 119 TABLE 142 REST OF EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY TYPE 2019–2032 (USD MILLION) 119 TABLE 143 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) 121 TABLE 144 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 121 TABLE 145 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 122 TABLE 146 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 122 TABLE 147 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 122 TABLE 148 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 123 TABLE 149 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 123 TABLE 150 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 123 TABLE 151 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 124 TABLE 152 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 124 TABLE 153 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 124 TABLE 154 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 125 TABLE 155 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 125 TABLE 156 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 125 TABLE 157 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 126 TABLE 158 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 126 TABLE 159 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 126 TABLE 160 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 127 TABLE 161 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 127 TABLE 162 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 127 TABLE 163 CHINA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 128 TABLE 164 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 128 TABLE 165 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 128 TABLE 166 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 129 TABLE 167 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 129 TABLE 168 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 129 TABLE 169 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 130 TABLE 170 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 130 TABLE 171 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 130 TABLE 172 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 131 TABLE 173 INDIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 131 TABLE 174 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 131 TABLE 175 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 132 TABLE 176 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 132 TABLE 177 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 132 TABLE 178 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 133 TABLE 179 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 133 TABLE 180 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 133 TABLE 181 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 134 TABLE 182 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 134 TABLE 183 JAPAN: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 134 TABLE 184 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 135 TABLE 185 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 135 TABLE 186 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 135 TABLE 187 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 136 TABLE 188 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 136 TABLE 189 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 136 TABLE 190 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 137 TABLE 191 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 137 TABLE 192 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 137 TABLE 193 AUSTRALIA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 138 TABLE 194 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 138 TABLE 195 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 138 TABLE 196 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 139 TABLE 197 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 139 TABLE 198 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 139 TABLE 199 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 140 TABLE 200 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 140 TABLE 201 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 140 TABLE 202 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 141 TABLE 203 SOUTH KOREA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 141 TABLE 204 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 141 TABLE 205 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 142 TABLE 206 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 142 TABLE 207 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 142 TABLE 208 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 143 TABLE 209 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 143 TABLE 210 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 143 TABLE 211 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 144 TABLE 212 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 144 TABLE 213 REST OF ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 144 TABLE 214 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2019–2032 (USD MILLION) 145 TABLE 215 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 146 TABLE 216 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 146 TABLE 217 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 147 TABLE 218 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 147 TABLE 219 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 147 TABLE 220 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 148 TABLE 221 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 148 TABLE 222 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 148 TABLE 223 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 149 TABLE 224 REST OF THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 149 TABLE 225 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 149 TABLE 226 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 150 TABLE 227 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 150 TABLE 228 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 150 TABLE 229 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 151 TABLE 230 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 151 TABLE 231 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 151 TABLE 232 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 152 TABLE 233 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 152 TABLE 234 MIDDLE EAST & AFRICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 152 TABLE 235 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION) 153 TABLE 236 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TOPICAL HEMOSTAT, BY TYPE, 2019–2032 (USD MILLION) 153 TABLE 237 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ADHESIVE & TISSUE SEALANT, BY TYPE, 2019–2032 (USD MILLION) 153 TABLE 238 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2019–2032 (USD MILLION) 154 TABLE 239 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 154 TABLE 240 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR TRAUMA, BY TYPE, 2019–2032 (USD MILLION) 154 TABLE 241 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR ACCIDENTS, BY TYPE, 2019–2032 (USD MILLION) 155 TABLE 242 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2019–2032 (USD MILLION) 155 TABLE 243 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, FOR HOSPITALS, BY TYPE, 2019–2032 (USD MILLION) 155 TABLE 244 SOUTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, F FOR AMBULATORY SURGICAL CENTERS, BY TYPE, 2019–2032 (USD MILLION) 156 TABLE 245 PUBLIC PLAYERS STOCK SUMMARY 160 TABLE 246 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 160 TABLE 247 PRODUCT LAUNCH/ PRODUCT APPROVAL 161 TABLE 248 ACQUISITION 161 TABLE 249 JOHNSON & JOHNSON SERVICES, INC: PRODUCT OFFERED 163 TABLE 250 JOHNSON & JOHNSON SERVICES, INC: KEY DEVELOPMENTS 164 TABLE 251 B. BRAUN SE: PRODUCT OFFERED 167 TABLE 252 MIL LABORATORIES PVT. LTD: PRODUCT OFFERED 169 TABLE 253 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 172 TABLE 254 BECTON, DICKINSON, AND COMPANY: KEY DEVELOPMENTS 173 TABLE 255 PFIZER INC.: PRODCUTS OFFERED 175 TABLE 256 TELEFLEX INCORPORATED: PRODUCTS OFFERED 178 TABLE 257 MEDTRONIC: PRODUCTS OFFERED 181 TABLE 258 BAXTER: PRODUCTS OFFERED 185 TABLE 259 MEDTRADE PRODUCTS LIMITED: PRODCUTS OFFERED 187 TABLE 260 MEDTRADE PRODUCTS LIMITED: KEY DEVELOPMENTS 188 TABLE 261 AXIO BIOSOLUTIONS PVT LTD: PRODCUTS OFFERED 190 TABLE 262 AXIO BIOSOLUTIONS PVT LTD: KEY DEVELOPMENTS 191 LIST OF FIGURES FIGURE 1 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: STRUCTURE FIGURE 2 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) FIGURE 5 VALUE CHAIN: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FIGURE 7 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION) FIGURE 8 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY PRODUCT, 2022 FIGURE 9 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY MATERIAL, 2022 & 2032 (USD MILLION) FIGURE 10 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY MATERIAL, 2022 FIGURE 11 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) FIGURE 12 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY APPLICATION, 2022 FIGURE 13 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY END USER, 2022 & 2032 (USD MILLION) FIGURE 14 GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY END USER, 2022 FIGURE 15 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2022 & 2032 (USD MILLION) FIGURE 16 GLOBAL: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY REGION, 2022 FIGURE 17 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) FIGURE 18 NORTH AMERICA: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 19 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION) FIGURE 20 EUROPE: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 21 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) FIGURE 22 ASIA-PACIFIC: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 23 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET, BY REGION, 2022 & 2030 (USD MILLION) FIGURE 24 REST OT THE WORLD: HEMOSTASIS AND TISSUE SEALING AGENTS MARKET SHARE (%), BY REGION, 2022 FIGURE 25 HEMOSTASIS AND TISSUE SEALING AGENTS MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 FIGURE 26 COMPETITOR DASHBOARD: GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET FIGURE 27 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 JOHNSON & JOHNSON SERVICES, INC: SWOT ANALYSIS FIGURE 29 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW FIGURE 31 PFIZER INC.: FINANCIAL OVERVIEW FIGURE 32 PFIZER INC.: SWOT ANALYSIS FIGURE 33 TELEFLEX INCORPORATED: FINANCIAL OVERVIEW FIGURE 34 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 35 MEDTRONIC: SWOT ANALYSIS FIGURE 36 BAXTER: FINANCIAL OVERVIEW SNAPSHOT FIGURE 37 BAXTER: SWOT ANALYSIS FIGURE 38 MEDTRADE PRODUCTS LIMITED: SWOT ANALYSIS

提及公司

Johnson & Johnson (US)B Braun Medical Inc (Germany)Teleflex Incorporated (US)Medtronic (Ireland)Baxter (US)Medtrade Products Limited (UK)Axio Biosolutions Pvt Ltd (India)MIL Laboratories Pvt. Ltd (India)BectonDickinsonand Company (US)and Pfizer Inc (US)

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們